Andrew Faughnan | Senior Director, IR |
Bradley Campbell | CEO, President & Director |
Sebastien Martel | Chief Business Officer |
Jeffrey Castelli | Chief Development Officer |
Daphne Quimi | CFO |
Anupam Rama | JPMorgan Chase & Co. |
Ritu Baral | Cowen and Company |
Joseph Schwartz | SVB Securities |
Dae Gon Ha | Stifel |
Zhiqiang Shu | Berenberg |
Ellie Merle | UBS |
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Second Quarter 2022 Financial Results Conference Call and Webcast. [Operator Instructions].
As a reminder, this call is being recorded. I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Executive Director of Investor Relations.